Literature DB >> 11709796

Growth inhibition of Candida albicans by human vaginal epithelial cells.

M M Barousse1, C Steele, K Dunlap, T Espinosa, D Boikov, J D Sobel, P L Fidel.   

Abstract

Vulvovaginal candidiasis (VVC) is a common mucosal infection caused by Candida species in women of childbearing age. Although acute VVC affects a large number of women and is often precipitated by hormonal fluctuations involving high estrogen levels, recurrent VVC (RVVC) affects another 5%-10% of women without any known predisposing factors. We have recently reported that vaginal epithelial cells from nonhuman primates and mice inhibit the growth of Candida albicans in vitro, which may represent an innate host defense mechanism against C. albicans at the vaginal mucosa. In the present study, we show that vaginal epithelial cells collected from healthy women with no history of VVC also exhibit anti-Candida activity, with no differences in activity at various stages of the menstrual cycle. Women diagnosed with RVVC, on the other hand, have reduced epithelial cell anti-Candida activity. These results are further evidence that vaginal epithelial cells provide an innate host resistance mechanism against Candida and that reduced activity may contribute to RVVC.

Entities:  

Mesh:

Year:  2001        PMID: 11709796     DOI: 10.1086/324532

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  25 in total

1.  Increased susceptibility of secretor factor gene Fut2-null mice to experimental vaginal candidiasis.

Authors:  Elizabeth A Hurd; Steven E Domino
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

Review 2.  Anticandidal immunity and vaginitis: novel opportunities for immune intervention.

Authors:  Antonio Cassone; Flavia De Bernardis; Giorgio Santoni
Journal:  Infect Immun       Date:  2007-06-11       Impact factor: 3.441

3.  Different Host Immunological Response to C. albicans by Human Oral and Vaginal Epithelial Cells.

Authors:  Ying Gao; Guanzhao Liang; Qiong Wang; Xiaodong She; Dongmei Shi; Yongnian Shen; Xiaohong Su; Xiang Wang; Wenmei Wang; Dongmei Li; Weida Liu
Journal:  Mycopathologia       Date:  2019-01-01       Impact factor: 2.574

4.  Genetic basis for recurrent vulvo-vaginal candidiasis.

Authors:  Martin Jaeger; Theo S Plantinga; Leo A B Joosten; Bart-Jan Kullberg; Mihai G Netea
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

5.  Candida-induced oral epithelial cell responses.

Authors:  E A Lilly; J E Leigh; S H Joseph; P L Fidel
Journal:  Mycopathologia       Date:  2006-07       Impact factor: 2.574

Review 6.  Cytokines in the host response to Candida vaginitis: Identifying a role for non-classical immune mediators, S100 alarmins.

Authors:  Junko Yano; Mairi C Noverr; Paul L Fidel
Journal:  Cytokine       Date:  2011-12-17       Impact factor: 3.861

7.  Vaginal and oral epithelial cell anti-Candida activity.

Authors:  Fatema Nomanbhoy; Chad Steele; Junko Yano; Paul L Fidel
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

8.  Candida-specific antibodies during experimental vaginal candidiasis in mice.

Authors:  Karen L Wozniak; Floyd L Wormley; Paul L Fidel
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

9.  Persistence of candiduria in ICU catheterized patients is not linked to adherence and proteolytic activities of Candida strains.

Authors:  Halis Akalin; Beyza Ener; Ferda Kahveci; Sevim Akçağlar; Saban Gürcan; Okan Töre
Journal:  Intensive Care Med       Date:  2004-03-09       Impact factor: 17.440

10.  Human dectin-1 deficiency and mucocutaneous fungal infections.

Authors:  Bart Ferwerda; Gerben Ferwerda; Theo S Plantinga; Janet A Willment; Annemiek B van Spriel; Hanka Venselaar; Clara C Elbers; Melissa D Johnson; Alessandra Cambi; Cristal Huysamen; Liesbeth Jacobs; Trees Jansen; Karlijn Verheijen; Laury Masthoff; Servaas A Morré; Gert Vriend; David L Williams; John R Perfect; Leo A B Joosten; Cisca Wijmenga; Jos W M van der Meer; Gosse J Adema; Bart Jan Kullberg; Gordon D Brown; Mihai G Netea
Journal:  N Engl J Med       Date:  2009-10-29       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.